David Bench - Jun 14, 2022 Form 4 Insider Report for ENZO BIOCHEM INC (ENZ)

Role
Chief Financial Officer
Signature
/s/ David Bench
Stock symbol
ENZ
Transactions as of
Jun 14, 2022
Transactions value $
$7,525
Form type
4
Date filed
6/15/2022, 04:31 PM
Previous filing
Apr 14, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ENZ Common Stock, $0.01 Par Value Purchase $7.53K +3.5K +140% $2.15 6K Jun 14, 2022 By Trust (PSP) F1
holding ENZ Common Stock, $0.01 Par Value 4.14K Jun 14, 2022 401k F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ENZ Stock Option (to acquire Common Stock) 87.5K Jun 14, 2022 Common Stock 87.5K $2.98 Direct F3
holding ENZ Stock Option (to acquire Common Stock) 87.5K Jun 14, 2022 Common Stock 87.5K $3.36 Direct F3
holding ENZ Stock Option (to acquire Common Stock) 55.4K Jun 14, 2022 Common Stock 55.4K $2.63 Direct F3
holding ENZ Stock Option (to acquire Common Stock) 55.4K Jun 14, 2022 Common Stock 55.4K $2.20 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares held by David Bench Consulty Group, a profit sharing plan of which the reporting person is a participant.
F2 Represents restricted shares granted subject the Company's discretionary matching contribution and non-elective employer contribution which vest ratable over four years of service, which began on December 23, 2019.
F3 The stock options have a five-year term and will vest in three equal instalments, one on the first anniversary of the grant date, the second on the second anniversary of the grant date and the third on the third anniversary of the grant date.